Literature DB >> 28858733

Quercetin attenuates the ischemia reperfusion induced COX-2 and MPO expression in the small intestine mucosa.

Štefan Tóth1, Zuzana Jonecová1, Kristína Čurgali1, Milan Maretta2, Ján Šoltés1, Martin Švaňa1, Theodore Kalpadikis1, Martin Caprnda3, Mariusz Adamek4, Luis Rodrigo5, Peter Kruzliak6.   

Abstract

Quercetin, the active substance of tea, fruits and vegetables, exerts a broad spectrum of pharmacological activities and is considered to have potential therapeutic application. The present study was designed to investigate the beneficial effect of quercetin against experimental ischemia- reperfusion (IR) injury of the small intestine in rats. Quercetin was administrated intraperitoneally 30min before 1h ischemia of superior mesenteric artery with following reperfusion periods lasting 1, 4 and 24h. The male specific pathogen-free Charles River Wistar rats were used (n=45). In acute phase, 4h after start of reperfusion, the quercetin induced a significant decrease in mucosal injury index (p<0.05) accompanied by a significant decrease in cyclooxygenase-2 (COX-2) expression in the epithelial lining of the intestinal villi in comparison with the control group (p<0.01). In the epithelium of the intestinal glands, COX-2 expression resulting from IR injury significantly increased regardless quercetin application (in control group p<0.001; in quercetin group p<0.05), but in quercetin group, significant decrease in it during 24h of reperfusion in a late phase of IR injury was detected (p<0.001). Based on morphology of COX-2 positive cells, the COX-2 positivity was found particularly in goblet cells of the intestinal villi epithelium and enteroendocrine cells respectively, in the glandular epithelium. We concluded that quercetin application attenuated mucosal damage from IR injury by inhibiting neutrophil infiltration which was demonstrated by a lower number of myeloperoxidase positive cells in the lamina propria during both phases of IR injury and the significant decrease in that in a late phase after 24h of reperfusion (p<0.05).
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  COX-2; Ischemia-reperfusion injury; MPO; Mucosal injury index; Quercetin; Small intestine

Mesh:

Substances:

Year:  2017        PMID: 28858733     DOI: 10.1016/j.biopha.2017.08.038

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  9 in total

1.  Phytochemical quercetin alleviates hyperexcitability of trigeminal nociceptive neurons associated with inflammatory hyperalgesia comparable to NSAIDs.

Authors:  Haruka Itou; Ryou Toyota; Mamoru Takeda
Journal:  Mol Pain       Date:  2022-04       Impact factor: 3.370

Review 2.  Pharmacological Effects of Polyphenol Phytochemicals on the Intestinal Inflammation via Targeting TLR4/NF-κB Signaling Pathway.

Authors:  Caiyun Yu; Dong Wang; Zaibin Yang; Tian Wang
Journal:  Int J Mol Sci       Date:  2022-06-22       Impact factor: 6.208

3.  Role of the antioxidant pathway in the healing of peptic ulcers induced by ischemia-reperfusion in male and female rats treated with Eugenia punicifolia.

Authors:  Larissa Lucena Périco; Raquel de Cássia Dos Santos; Vinícius Peixoto Rodrigues; Vânia Vasti Alfieri Nunes; Wagner Vilegas; Lúcia Regina Machado da Rocha; Catarina Dos Santos; Clélia Akiko Hiruma-Lima
Journal:  Inflammopharmacology       Date:  2022-04-20       Impact factor: 5.093

4.  Extract of Pinus densiflora needles suppresses acute inflammation by regulating inflammatory mediators in RAW264.7 macrophages and mice.

Authors:  Seul-Yong Jeong; Won Seok Choi; Oh Seong Kwon; Jong Seok Lee; Su Young Son; Choong Hwan Lee; Sarah Lee; Jin Yong Song; Yeon Jin Lee; Ji-Yun Lee
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

5.  Study on the mechanism of the Modified Ginseng-Schisandra Decoction (MGSD) in the treatment of recurrent respiratory tract infection (RRTI) based on network pharmacology.

Authors:  Qing-Ke Cui; Hua Li; Zhan Li; Jie Li; Liqi Song
Journal:  Transl Pediatr       Date:  2021-06

6.  Identifying Synergistic Mechanisms of Multiple Ingredients in Shuangbai Tablets against Proteinuria by Virtual Screening and a Network Pharmacology Approach.

Authors:  Xiaoqin Ma; Meixiang Yu; Chenxia Hao; Wanhua Yang
Journal:  Evid Based Complement Alternat Med       Date:  2020-01-06       Impact factor: 2.629

7.  Mechanism of Action of Bu-Fei-Yi-Shen Formula in Treating Chronic Obstructive Pulmonary Disease Based on Network Pharmacology Analysis and Molecular Docking Validation.

Authors:  Longchuan Wu; Yu Chen; Jiao Yi; Yi Zhuang; Lei Cui; Chunhui Ye
Journal:  Biomed Res Int       Date:  2020-11-26       Impact factor: 3.411

8.  Protective effect of parecoxib sodium against ischemia reperfusion‑induced intestinal injury.

Authors:  Mei Li; Zhi Zheng
Journal:  Mol Med Rep       Date:  2021-09-09       Impact factor: 2.952

9.  Recombinant Human Annexin A5 Alleviated Traumatic-Brain-Injury Induced Intestinal Injury by Regulating the Nrf2/HO-1/HMGB1 Pathway.

Authors:  Hejun Zhang; Yalong Gao; Tuo Li; Fanjian Li; Ruilong Peng; Cong Wang; Shu Zhang; Jianning Zhang
Journal:  Molecules       Date:  2022-09-06       Impact factor: 4.927

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.